SINI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.053
AS - Asia 97
EU - Europa 74
SA - Sud America 20
AF - Africa 1
Totale 1.245
Nazione #
US - Stati Uniti d'America 1.047
SG - Singapore 43
CN - Cina 25
IE - Irlanda 20
BR - Brasile 13
RU - Federazione Russa 13
IT - Italia 10
UA - Ucraina 9
HK - Hong Kong 8
DE - Germania 7
FR - Francia 5
VN - Vietnam 5
GB - Regno Unito 4
KR - Corea 4
CO - Colombia 3
IN - India 3
JP - Giappone 3
CA - Canada 2
EC - Ecuador 2
FI - Finlandia 2
JM - Giamaica 2
SE - Svezia 2
AL - Albania 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
EG - Egitto 1
IQ - Iraq 1
MN - Mongolia 1
MX - Messico 1
PL - Polonia 1
SY - Repubblica araba siriana 1
TR - Turchia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.245
Città #
Houston 303
Wilmington 255
Woodbridge 254
Fairfield 42
Ashburn 30
Singapore 26
Cambridge 18
Chandler 16
Seattle 16
Beijing 11
San Jose 10
Dublin 9
Medford 9
Hong Kong 8
Jacksonville 8
The Dalles 7
Ann Arbor 4
Lawrence 4
Palo Alto 4
Redwood City 4
Rome 4
Detroit 3
Los Angeles 3
Moscow 3
San Diego 3
Santa Clara 3
Dearborn 2
Falls Church 2
Guayaquil 2
Lauterbourg 2
Manassas 2
Naples 2
Pisa 2
Redondo Beach 2
Seoul 2
São Paulo 2
Alta Floresta 1
Alto Hospicio 1
Amritsar 1
Araguari 1
Baghdad 1
Biên Hòa 1
Boardman 1
Buffalo 1
Camboriú 1
Caracas 1
Chennai 1
Chicago 1
Dallas 1
Frankfurt am Main 1
Gravatá 1
Greenville 1
Hanoi 1
Hebei 1
Hefei 1
Ho Chi Minh City 1
Istanbul 1
Itaitinga 1
Jalandhar 1
Kingston 1
London 1
Manama 1
Manizales 1
Montreal 1
Mountain View 1
Nanchang 1
Nanjing 1
New York 1
Nuremberg 1
Olímpia 1
Orem 1
Palhoça 1
Portmore 1
Prescot 1
Quzhou 1
Redmond 1
San José 1
San Nicolás de los Garza 1
Sevilla 1
Soacha 1
Taboão da Serra 1
Tanta 1
Tashkent 1
Temecula 1
Thái Nguyên 1
Tirana 1
Tokyo 1
Toronto 1
Três Rios 1
Ulan Bator 1
Vitória 1
Warsaw 1
Totale 1.133
Nome #
Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer 432
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: Pros and cons 420
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 214
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 189
Totale 1.255
Categoria #
all - tutte 3.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 5 5 1
2021/202253 6 7 1 1 0 1 10 2 2 4 10 9
2022/202341 5 3 0 6 2 13 1 2 6 0 2 1
2023/202410 2 0 2 0 3 0 0 0 1 0 0 2
2024/202567 3 18 6 4 0 11 2 1 9 4 6 3
2025/2026121 8 7 17 12 19 6 8 20 18 6 0 0
Totale 1.255